Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices.


PURPOSE The purpose of this project was to characterize the use of heart failure medications during the first year after left-ventricular assist device (LVAD) implantation. METHODS All patients who received a HeartMate II at our institution between January 1, 2007, and August 1, 2009, and were followed by our multidisciplinary team for at least 6 months… (More)
DOI: 10.5301/ijao.5000068


  • Presentations referencing similar topics